Abstract
The in vivo effect of rifampicin, a potent ligand of PXR, on gene expression of CYP2B22, 3A22, 3A29, 3A46, CAR, PXR and MDR1, MRP1, MRP2, LRP transporters in liver and cortex, cerebellum, midbrain, hippocampus, meninges and brain capillaries of pig was investigated. Animals were treated i.p. with four daily doses of rifampicin (40 mg/kg). The basal mRNA expressions of the individual CYP3As, CYP2B22, CAR, and PXR in various brain regions, except meninges, were about or below 10% of the corresponding hepatic mRNA values, whereas the mRNAs of brain transporters were closer or comparable to those in liver. After pig treatment with rifampicin, the mRNA expression of CYPs and transporters from brain regions did not appear to change, except CYP3A22 and 3A29 in cortex and hippocampus, CYP2B22 in meninges. An enzymatic analysis for CYP3As and CYP2B, in microsomes and mitochondria from liver and brain tissues using the marker activities 7-benzyloxyquinoline O-debenzylase and the anthraldehyde oxidase, showed the lack of rifampicin induction in all the brain regions, unlike liver. Taken together, our results demonstrate that CYP2B22, CYP3As, and MDR1, MRP1, MRP2, and LRP transporters are all expressed, although at different extent, in the brain regions but, despite the presence of PXR and CAR, are resistant to induction indicating that the regulation of these proteins is more complex in brain than in liver. These data obtained in vivo in the brain regions and liver of pig may be of interest to human metabolism in CNS.
Similar content being viewed by others
Abbreviations
- CYP:
-
Cytochrome P450
- CNS:
-
Central nervous system
- RIF:
-
Rifampicin
- PCN:
-
Pregnegnolone-16α-carbonitrile
- AnOx:
-
9-Anthraldehyde oxidase
- BQD:
-
7-Benzyloxyquinoline O-debenzylase
- GAPDH:
-
Glyceraldehyde 6-phosphate dehydrogenase
- PXR:
-
Pregnane X receptor
- CAR:
-
Constitutive androstane receptor
- MDR:
-
Multidrug resistance
- MRP:
-
Multidrug resistance-associated protein
- LRP:
-
Lung resistance-related protein
- BBB:
-
Blood–brain barrier
References
Guengerich FP (2005) Human cytochrome P450 enzymes. In: Ortiz de Montellano R (ed) Cytochrome P450, structure, mechanism and biochemistry, 3rd edn. Kluwer Academic, New York, pp 377–463
Ravindranath V, Boyd MR (1995) Xenobiotic metabolism in brain. Drug Metab Rev 27:419–448
Hedlund E, Gustafsson JA, Warner M (2001) Cytochrome P450 in the rat brain: a review. Curr Drug Metab 2:245–263
Strobel HW, Thompson CM, Antonovic L (2001) Cytochrome P450 in brain: function and significance. Curr Drug Metab 2:199–214
Meyer RP, Gehlhaus M, Knoth R, Volk B (2007) Expression and function of cytochrome P450 in brain metabolism. Curr Drug Metab 8:297–306
Miksys SL, Tyndale RF (2002) Drug-metabolizing cytochrome P450s in the brain. J Psychiatry Neurosci 27:406–415
Voodland C, Huang TT, Gryz E, Bendayan R, Fawcett JP (2008) Expression activity and regulation of CYP3A in human and rodent brain. Drug Metab Rev 40:149–168
Hagemeyer CE, Rosenbrock H, Ditter M, Koth R, Volk B (2003) Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 117:521–529
Rosenbrock H, Hagemeyer CE, Singec I, Knoth R, Volk B (1999) Testosterone metabolism in brain rat is differentially enhanced by phenytoin-inducible cytochrome P450 isoforms. J Neuroendocrinol 11:597–604
Wang H, Strobel HW (1997) Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P4503A9 expressed in Escherichia coli. Arch Biochem Biophys 344:365–372
Schilter B, Omiecinski CJ (1993) Regional distribution and expression modulation of cytochrome P450 and epoxide hydrolase mRNA in the rat brain. Mol Pharmacol 44:990–996
Upadhya SC, Chinta SJ, Pai HV, Boyd MR, Ravindranath V (2002) Toxicological consequences of differential regulation of cytochrome P450 isoforms in rat brain regions by phenobarbital. Arch Biochem Biophys 399:56–65
Yadav S, Dhawan A, Seth PK, Singh RL, Parmar D (2006) Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain. Mol Cell Biochem 287:91–99
Marini S, Nannelli A, Sodini D, Dragoni S, Valoti M, Longo V, Gervasi PG (2007) Expression, microsomal and mitochondrial activities of cytochrome P450 enzymes in brain regions from control and phenobarbital-treated rabbits. Life Sci 80:910–917
McFadyen MC, Melvin WT, Murray GI (1998) Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol 55:825–830
Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S, Schuetz EG (2004) PXR (NR112): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 199:251–265
Kliewer SA, Goodwin B, Willson TM (2002) The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23:687–702
Gibson GG, Plant NJ, Swales KE, Ayrton A, El-Sankary W (2002) Receptor-dependent transcription activation of cytochrome P4503A genes: induction mechanism, species differences and interindividual variation in man. Xenobiotica 32:165–206
Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA (2001) Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor. Mol Pharmacol 60:427–431
Synold TW, Dussault L, Forman BM (2001) The orphan nuclear receptor SXR co-ordinately regulates drug metabolism and efflux. Nat Med 7:584–590
Geick A, Eichelbaum M, Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581–14587
Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottruff BS, Cabrera GY, Tukey RH, Evans RM (2003) Control of steroid, heme and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci USA 100:4150–4155
Johnson DR, Klaassen CD (2002) Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways. Toxicol Sci 67:182–189
Maher JM, Slitt AL, Cherrington NJ, Cheng X, Klaassen CD (2005) Tissue distribution and hepatic and renal ontogeny of the multidrug resistance-associated protein (MRP) family in mice. Drug Metab Dispos 33:947–955
Nishimura M, Naito S, Yokoy T (2004) Tissue-specific mRNA expression profiles of human nuclear receptor subfamily. Drug Metab Pharmacokinet 19:135–149
Dallas S, Miller DS, Bendayan R (2006) Multidrug resistance-associated proteins: expression and function in the central nervous system. Pharmacol Rev 58:140–161
Aquilante CL, Letrent SP, Pollack GM, Brower KLR (2000) Increased brain p-glycoprotein in morphine tolerant rats. Life Sci 66:47–51
Matheny CJ, Ali RY, Yang X, Pollack GM (2004) Effect of prototypical inducing agents on p-glycoprotein and CYP3A expression in mouse tissues. Drug Metab Dispos 32:1008–1014
Bauer B, Hartz AMS, Fricker G, Miller DS (2004) Pregnane X receptor up-regulation of p-glycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 66:413–419
Mei Q, Richards K, Strong-Basalyga K, Fauty SE, Taylor A, Yamazaki M, Prueksaritanont T, Lin JH, Hochman J (2004) Using real-time quantitative TaqMan RT-PCR to evaluate the role of dexamethasone in gene regulation of rat p-glycoproteins mdr1a/1b and cytochrome P4503A1/2. J Pharm Sci 93:2488–2496
Swindle MM, Smith AC (1998) Comparative anatomy and physiology of the pig. Scand J Lab Anim Sci 25(Suppl 1):11–22
Longo V, Mazzaccaro A, Naldi F, Gervasi PG (1991) Drug metabolizing enzymes in liver, olfactory and respiratory epithelium of cattle. J Biochem Toxicol 6:123–128
Mrsulja BB, Mrsulja BJ, Fujimoto T, Klatzo L, Spetz M (1976) Isolation of brain capillaries: a simplified technique. Brain Res 110:361–365
Sims NR (1990) Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation. J Neurochem 55:698–707
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Stresser DM, Blanchard AP, Turner SD, Erve JCL, Dandeneau AA, Miller VP, Crespi LC (2000) Substrate-dependent modulation of CYP3A catalytic activity: analysis of 27 test compounds with four fluorimetric substrates. Drug Metab Dispos 28:1440–1448
Marini S, Grasso E, Longo V, Puccini P, Riccardi B, Gervasi PG (2003) 4-Biphenylaldehyde and 9-anthraldehyde. Two fluorescent substrates for determining P450 enzyme activities in rat and human. Xenobiotica 33:1–11
Amato G, Longo V, Mazzaccaro A, Gervasi PG (1996) Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver. Chem Res Toxicol 9:882–890
Ghosal A, Hapangama N, Yuan Y, Favreau LV, Palamanda JR, Partick JE, Cayen MN, Zbaida S (2000) Microtiter plate-based assay for rapid determination of enzyme activities of 13 P-450 supersomes and human liver microsomes. Drug Metab Rev 32(Suppl 2):188–197
Nannelli A, Chirulli V, Longo V, Giovanni PG (2008) Expression and induction by rifampicin of CAR- and PXR- regulated CYP2B and CYP3As in liver kidney and airways of pig. Toxicology 252:105–112
Messina A, Chirulli V, Gervasi PG, Longo V (2008) Purification, molecular cloning, heterologous expression and characterization of pig CYP1A2. Xenobiotica 38:1453–1470
Liu M, Hurn PD, Alkayed NJ (2004) Cytochrome P450 in neurological disease. Curr Drug Metab 5:225–234
Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T (2003) Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 123:369–375
Meyer RP, Hagemeyer CE, Knoth R, Kaufmann MR, Volk B (2006) Anti-epilectic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J Neurochem 96:460–472
Fleming J (2001) Cytochrome P450 enzymes in vascular homeostasis. Circ Res 89:753–762
Schilter B, Andersen MR, Acharya C, Omiecinski CJ (2000) Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. J Pharmacol Exp Ther 294:916–922
Mindermann T, Zimmerli W, Gratzl O (1998) Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother 42:2626–2629
Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, Thompson E, Strom S, Schuetz EG (2004) Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 311:811–821
Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Ducan SA, Inoue Y, Gonzalez FJ, Schuetz E, Kim RB (2003) The orphan nuclear receptor HNF4α determines PXR-and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9:220–224
Nishimura M, Koeda A, Suzuki E, Kawano Y, Nakayama M, Satoh T, Narimatsu S, Naito S (2006) Regulation of mRNA expression of MDR1, MRP1, MRP2 and MRP3 by prototypical microsome enzyme inducers in primary cultures of human and rat hepatocytes. Drug Metab Pharmacokinect 21:297–307
Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenheiss J, Burchell B, Keppler D (1997) ATP-dependent transport of bilirubin glucuronides by the multidrug resistant protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 327(Pt 1):305–310
Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stolz CM, Tontonoz P, Kliewer S, Willson TM, Edwards PA (2002) Regulation of multidrug regulated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor and constitutive androstane receptor. J Biol Chem 277:2908–2915
Salphati L, Benet LZ (1998) Modulation of p-glycoprotein expression by cytochrome P4503A inducers in male and female rat livers. Biochem Pharmacol 55:387–395
Wacher VJ, Wu CY, Benet LZ (1995) Overlapping substrate specificity and tissue distribution of cytochrome P4503A and p-glycoprotein: implications from drug delivery and activity in cancer chemotherapy. Mol Carcinog 13:129–134
Kim RB, Wandel C, Laeke B, Cvetkovic M, Fromm MF, Demsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJJ, Wilkinson GR (1999) Interrelationship between substrates and inhibitors of human CYP3A and p-glycoprotein. Pharmacol Res 16:408–414
Leslie EM, Deeley RG, Cole SPC (2005) Multidrug resistance proteins: role of p-glycoprotein, MRP1, MRP2 and BCRP (ABCG2) in tissue defence. Toxicol Appl Pharmacol 204:216–237
Zhang Y, Li CSW, Ye Y, Johnson K, Poe J, Johnson S, Bobrowski W, Garrido R, Madhu C (2006) Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos 34:1935–1943
Bauer B, Hartz AMS, Lucking JR, Yang X, Pollack GM, Miller DS (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolising enzyme, GSTπ, at the blood-brain barrier. J Cereb Blood Flow Metab 28:1222–1234
Labialle S, Gayet L, Marthinet R, Rigal D, Baggetto LG (2002) Transcriptional regulators of the human multidrug resistance 1 gene: recent views. Biochem Pharmacol 64:943–948
Seul W, Choi HS, Moore DD (1996) An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science 272:1336–1339
Acknowledgments
We acknowledge Dr. Luigi Malvasi and the Prof. Anna Zaghini of “dip. Sanita’ Pubblica Vaterinaria e Patologia Animale” of Bologna University for pig supply and treatments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nannelli, A., Rossignolo, F., Tolando, R. et al. Expression and distribution of CYP3A genes, CYP2B22, and MDR1, MRP1, MRP2, LRP efflux transporters in brain of control and rifampicin-treated pigs. Mol Cell Biochem 337, 133–143 (2010). https://doi.org/10.1007/s11010-009-0292-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0292-1